Tests:Procalcitonin: Difference between revisions

From Taranaki Lab Manual
Tests:Procalcitonin
Jump to navigation Jump to search
m Mark as reviewed
Updated method Alinity
Line 114: Line 114:
|-
|-
|Test Method  
|Test Method  
|Abbott Alinity Ci analyser, using Abbott reagents.    
|Abbott Alinity i series analyser using Abbott RegentsChemiluminescent microparticle immunoassay.
|-
|-
|Advanced Notice  
|Advanced Notice  

Revision as of 20:19, 23 September 2026

Overview

Department Biochemistry
Test Code PCTN
Synonyms PCT

PCTN  

Availability Monday - Sunday, testing routinely available out of hours
Turnaround Time 2 hours
Stability – Add test 8 hours unseparated  

48 hours when separated from the cells and/or gel

Specimen Requirements

Specimen Plasma

Serum

Preferred 6 mL Li-Hep Green-Top
Acceptable 6 mL Plain Red-Top 
Unacceptable Grossly haemolysed samples
Specimen Transportation
Paediatric Requirements   600 µL Li-Hep Microtainer   

Aliquot Requirements

Sample Serum

Plasma  

Preferred Volume 1 mL
Minimum Volume 0.3 mL
Aliquot Transportation

Clinical Information

Reference Intervals There are two ranges: Standard ranges and associated comments, and ranges for neonates within the first 48hrs after birth.  

 Standard ranges:  

PCT <0.5 ng/mL – Systemic infection (sepsis) is unlikely.  Local bacterial infection is possible.  

PCT >0.5 and <2 ng/mL – Systemic infection is possible but take into count the various conditions are known to induce PCT as well.  

PCT >2 and <10 ng/mL – Systemic infection is likely, unless other causes known.  

PCT >10 ng/mL – Important SIRS almost exclusively due to bacterial sepsis or septic shock.  

 Neonate ranges:  

Age in hours PCT ng/m
0-6 < 2
6-12 < 8
12-18 < 15
18-30 < 21
30-36 < 15
33-42 < 8
42-48 < 2
Test Method Abbott Alinity i series analyser using Abbott Regents.  Chemiluminescent microparticle immunoassay.
Advanced Notice Not required    
Patient Preparation Not required    

Comments

PCT levels can be increased in certain circumstances without infectious origin.  These include, but are not limited to:  
  • Prolonged or severe cardiogenic shock  
  • Prolonged severe organ perfusion anomalies  
  • Small cell lung cancer or medullary C-cell carcinoma of the thyroid  
  • Early after major trauma, major surgery intervention, severe burns  
  • Treatments which stimulate the release of pro-inflammatory cytokines
Owner Clair Crossley (Crossley1)
Last reviewed 23.09.2026
Next review 23.09.2027 (OK)